Ovoca Bio PLC
LSE:OVB
Ovoca Bio PLC
Net Income (Common)
Ovoca Bio PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ovoca Bio PLC
LSE:OVB
|
Net Income (Common)
-€2.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
10%
|
|
Perrigo Company PLC
NYSE:PRGO
|
Net Income (Common)
-$7.7m
|
CAGR 3-Years
68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Net Income (Common)
$330.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
15%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Net Income (Common)
-$156.8m
|
CAGR 3-Years
-204%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Net Income (Common)
-$35.6m
|
CAGR 3-Years
-329%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Net Income (Common)
€1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-34%
|
See Also
What is Ovoca Bio PLC's Net Income (Common)?
Net Income (Common)
-2.3m
EUR
Based on the financial report for Jun 30, 2023, Ovoca Bio PLC's Net Income (Common) amounts to -2.3m EUR.
What is Ovoca Bio PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
10%
Over the last year, the Net Income (Common) growth was 71%. The average annual Net Income (Common) growth rates for Ovoca Bio PLC have been 12% over the past three years , -10% over the past five years , and 10% over the past ten years .